| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/31/2001 | WO2001038503A2 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | WO2001038502A2 Oleoyl-acyl-carrier-protein thioesterases in plants |
| 05/31/2001 | WO2001038500A2 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 05/31/2001 | WO2001038497A1 Duck pneumovirus and corresponding vaccines |
| 05/31/2001 | WO2001038496A1 A human normal counterpart of cd4+ cd56+ cutaneous neoplasm |
| 05/31/2001 | WO2001038495A2 Method for producing a thrombocyte preparation and a thrombocyte preparation |
| 05/31/2001 | WO2001038494A1 Method of proliferating natural killer cells |
| 05/31/2001 | WO2001038493A1 Treatment of human infertility |
| 05/31/2001 | WO2001038490A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038393A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 05/31/2001 | WO2001038392A1 Novel transcription factor and dna thereof |
| 05/31/2001 | WO2001038362A2 Production of vaccines |
| 05/31/2001 | WO2001038361A1 Modified adenovirus fibre and uses |
| 05/31/2001 | WO2001038360A2 Novel hcv non-structural polypeptide |
| 05/31/2001 | WO2001038358A2 Hbv/hcv virus-like particle |
| 05/31/2001 | WO2001038355A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 05/31/2001 | WO2001038348A2 G-protein coupled receptor htogh35 |
| 05/31/2001 | WO2001038344A2 Modulation of signal transduction |
| 05/31/2001 | WO2001038339A1 Antimitotic compounds |
| 05/31/2001 | WO2001037889A2 Injectable bone-substitute material |
| 05/31/2001 | WO2001037884A2 Improved tissue engineered blood vessels and methods and apparatus for their manufacture |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037852A2 Methods of inhibiting atrophy or promoting hypertrophy |
| 05/31/2001 | WO2001037850A2 Use of a milk protein hydrolysate in the treatment of diabetes |
| 05/31/2001 | WO2001037736A1 Method for individual selection of optimal nutrition of a human being |
| 05/31/2001 | WO2001037671A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | WO2001037656A2 Preservation of sensitive biological material |
| 05/31/2001 | WO2001037655A1 Method of cryopreserving selected sperm cells |
| 05/31/2001 | WO2001012782A3 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
| 05/31/2001 | WO2001011030A3 Method and means for inducing cell-multiplication of non-active cells |
| 05/31/2001 | WO2001002598A3 Screening for compounds modulating mitochondrial proton leak |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000078975A3 Rice sucrose synthase promoter |
| 05/31/2001 | WO2000078931A3 Neuronal cell material, use of said material as a transplant and method for producing the same |
| 05/31/2001 | WO2000077229A3 R1 protein from wheat and the use thereof for the production of modified strach |
| 05/31/2001 | WO2000070022A3 Ex vivo expansion of mammalian hematopoietic stem cells |
| 05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/31/2001 | WO2000061754A3 Human proteins and polynucleotides encoding them |
| 05/31/2001 | WO2000055345A3 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 05/31/2001 | WO2000053630A3 COMPOUNDS THAT DISRUPT MAMMALIAN Rad51 ACTIVITY |
| 05/31/2001 | WO2000042165A3 Bone marrow-specific protein |
| 05/31/2001 | WO2000032772A3 Erythropoietic compounds |
| 05/31/2001 | WO2000017327A3 Terpene synthases |
| 05/31/2001 | WO2000015758A3 Plant resistance to insect pests mediated by viral proteins |
| 05/31/2001 | WO2000012735A3 Transgene assay using stable agrobacterium rhizogenes transformation |
| 05/31/2001 | WO2000006712A3 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 05/31/2001 | WO1999028462A9 Polypeptides and nucleic acids encoding the same |
| 05/31/2001 | US20010002490 Method of increasing growth and yield in plants |
| 05/31/2001 | US20010002489 Methods for increasing stearate content in soybean oil |
| 05/31/2001 | DE19959750C1 Production of skin implant, e.g. for treating burn or other open wound, uses flat element of fine biocompatible, biodegradable or bioresorbable fibers of hydrolytically condensed silicon compound on nutrient solution |
| 05/31/2001 | DE19954775A1 Non-Darwinian breeding method, useful for controlling resistant pathogens and pests, by selection and reproduction of weakest organisms not immune to stress factors |
| 05/31/2001 | DE19954444A1 Verfahren zum Schutz von Säugetierzellen mittels überexprimierter G-2/M-Zellzykluskoppler A method of protecting mammalian cells by means of overexpressed G-2 / M-Zellzykluskoppler |
| 05/31/2001 | CA2396392A1 Methods and compositions for the introduction of molecules into cells |
| 05/31/2001 | CA2394827A1 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/31/2001 | CA2394803A1 Novel human protein kinases and protein kinase-like enzymes |
| 05/31/2001 | CA2393322A1 Method of proliferating natural killer cells |
| 05/31/2001 | CA2393126A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/31/2001 | CA2392649A1 Assay of isomerised and/or optically inverted proteins |
| 05/31/2001 | CA2392639A1 G-protein coupled receptor htogh35 |
| 05/31/2001 | CA2392527A1 Hbv/hcv virus-like particle |
| 05/31/2001 | CA2392495A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/31/2001 | CA2392470A1 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
| 05/31/2001 | CA2392400A1 A human normal counterpart of cd4+ cd56+ cutaneous neoplasm |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392351A1 Novel transcription factor and dna thereof |
| 05/31/2001 | CA2392272A1 Modified adenovirus fibre and uses |
| 05/31/2001 | CA2392217A1 Methods of inhibiting atrophy or promoting hypertrophy |
| 05/31/2001 | CA2392019A1 Method of forming a peptide-receptor complex with zsig33 |
| 05/31/2001 | CA2391434A1 Anti-angiogenic cellular agent for cancer therapy |
| 05/31/2001 | CA2391379A1 Preservation of sensitive biological material |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2389667A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/31/2001 | CA2387044A1 Oleoyl-acyl-carrier-protein thioesterases in plants |
| 05/30/2001 | EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 05/30/2001 | EP1103616A2 Synthetic plant genes and method for preparation |
| 05/30/2001 | EP1103615A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103610A1 Production of vaccines from immortalised mammalian cell lines |
| 05/30/2001 | EP1103602A1 New lymphocytes, a process for preparing the same and their use, in therapeutics |
| 05/30/2001 | EP1103601A1 A method for culturing cell and a culture vessel |
| 05/30/2001 | EP1103265A1 T-cells specific for polymorphic proteins on malignant cells |
| 05/30/2001 | EP1102992A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 05/30/2001 | EP1102977A1 Fluorescence assay for biological systems |
| 05/30/2001 | EP1102976A1 Multiple frequency fluorescence lifetime imaging |
| 05/30/2001 | EP1102864A1 Gel microdrops in genetic analysis |
| 05/30/2001 | EP1102863A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
| 05/30/2001 | EP1102858A2 Cell lines for the propagation of mutated herpes viruses |
| 05/30/2001 | EP1102857A2 Controlling starch synthesis |
| 05/30/2001 | EP1102856A1 Method of increasing the resistance of cultivated plants to phytopathogenic fungi and bacteria by methods of molecular genetics |
| 05/30/2001 | EP1102855A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 05/30/2001 | EP1102854A1 Method for increasing the resistance of cultivated plants to chemical stress |
| 05/30/2001 | EP1102853A1 N-acetylglycosaminyltransferase genes |
| 05/30/2001 | EP1102849A2 A plant disease resistance signalling gene: materials and methods relating thereto |
| 05/30/2001 | EP1102846A1 Pancreatic and ovarian polypeptide, zsig58 |
| 05/30/2001 | EP1102844A2 Human neuronal acid-sensitive cationic channel, its cloning and applications |
| 05/30/2001 | EP1102841A2 Method for selective and optionally reversible degeneration of somatic plant tissue |
| 05/30/2001 | EP1102840A2 Transgenic animals having a modified glycoprotein v gene |
| 05/30/2001 | EP1102791A1 Modified green fluorescent protein |
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |